195 related articles for article (PubMed ID: 29527033)
21. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
Paulson ML; Freeman AF; Holland SM
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
[TBL] [Abstract][Full Text] [Related]
22. Elevated serum immunoglobulin E (IgE): when to suspect hyper-IgE syndrome-A 10-year pediatric tertiary care center experience.
Joshi AY; Iyer VN; Boyce TG; Hagan JB; Park MA; Abraham RS
Allergy Asthma Proc; 2009; 30(1):23-7. PubMed ID: 19331717
[TBL] [Abstract][Full Text] [Related]
23. A novel large deletion of the DOCK8 gene in a Chinese family with autosomal-recessive hyper-IgE syndrome.
Xue L; Yang Y; Wang S
J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):599-601. PubMed ID: 24673638
[TBL] [Abstract][Full Text] [Related]
24. Pediatric hyperimmunoglobulin E syndrome (Job's syndrome) with STAT3 mutation: A case report.
Bhutani N; Sharma U; Kumar A; Kajal P
Ann Med Surg (Lond); 2021 Jun; 66():102452. PubMed ID: 34141423
[TBL] [Abstract][Full Text] [Related]
25. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.
Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B
J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316
[TBL] [Abstract][Full Text] [Related]
26. Hyper-IgE syndrome: a case report.
Dave T; Tashrifwala FAA; Rangwala US; Hameed R
Ann Med Surg (Lond); 2024 Feb; 86(2):1205-1209. PubMed ID: 38333292
[TBL] [Abstract][Full Text] [Related]
27. An Update on Syndromes with a Hyper-IgE Phenotype.
Bergerson JRE; Freeman AF
Immunol Allergy Clin North Am; 2019 Feb; 39(1):49-61. PubMed ID: 30466772
[TBL] [Abstract][Full Text] [Related]
28. Clinical features, STAT3 gene mutations and Th17 cell analysis in nine children with hyper-IgE syndrome in mainland China.
Zhang LY; Tian W; Shu L; Jiang LP; Zhan YZ; Liu W; Zhao XD; Cui YX; Tang XM; Wang M; Wu DQ; Yang XQ
Scand J Immunol; 2013 Sep; 78(3):258-65. PubMed ID: 23659370
[TBL] [Abstract][Full Text] [Related]
29. Hyper-IgE syndromes.
Grimbacher B; Holland SM; Puck JM
Immunol Rev; 2005 Feb; 203():244-50. PubMed ID: 15661034
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic challenge in a series of eleven patients with hyper IgE syndromes.
Yaakoubi R; Mekki N; Ben-Mustapha I; Ben-Khemis L; Bouaziz A; Ben Fraj I; Ammar J; Hamzaoui A; Turki H; Boussofara L; Denguezli M; Haddad S; Ouederni M; Bejaoui M; Chan KW; Lau YL; Mellouli F; Barbouche MR; Ben-Ali M
Front Immunol; 2022; 13():1057679. PubMed ID: 36703986
[TBL] [Abstract][Full Text] [Related]
31. Acute disseminated encephalomyelitis: an uncommon presentation of hyper IgE syndrome.
Purkait R; Kar S; Bhadra R; Sinhamahapatra T
J Coll Physicians Surg Pak; 2014 Nov; 24 Suppl 3():S256-8. PubMed ID: 25518794
[TBL] [Abstract][Full Text] [Related]
32. Hyper IgE recurrent infection syndrome in South Asia: is there a different outcome?
de Silva R; Dasanayake D; Senanayake M; Ediriweera R; Dias S; Karunatilleke C; Brocas K; Tahami F; Seneviratne S
Allergy Asthma Clin Immunol; 2018; 14():70. PubMed ID: 30410549
[TBL] [Abstract][Full Text] [Related]
33. Hyper-IgE syndrome with a novel STAT3 mutation-a single center study from India.
Saikia B; Suri D; Goel S; Rawat A; Minz RW; Gupta A; Sharma S; Ohara O; Imai K; Nonoyama S; Sehgal S; Singh S
Asian Pac J Allergy Immunol; 2014 Dec; 32(4):321-7. PubMed ID: 25543043
[TBL] [Abstract][Full Text] [Related]
34. Partial and Transient Clinical Response to Omalizumab in IL-21-Induced Low STAT3-Phosphorylation on Hyper-IgE Syndrome.
Alonso-Bello CD; Jiménez-Martínez MDC; Vargas-Camaño ME; Hierro-Orozco S; Ynga-Durand MA; Berrón-Ruiz L; Alcántara-Montiel JC; Santos-Argumedo L; Herrera-Sánchez DA; Lozano-Patiño F; Castrejón-Vázquez MI
Case Reports Immunol; 2019; 2019():6357256. PubMed ID: 31355024
[TBL] [Abstract][Full Text] [Related]
35. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome.
Minegishi Y; Saito M; Tsuchiya S; Tsuge I; Takada H; Hara T; Kawamura N; Ariga T; Pasic S; Stojkovic O; Metin A; Karasuyama H
Nature; 2007 Aug; 448(7157):1058-62. PubMed ID: 17676033
[TBL] [Abstract][Full Text] [Related]
36. Hyper-IgE syndrome in an 11 year old female presenting with acneiform rash.
Byrne B; Hefferon T; Harrington R; Leahy M; Murphy A
Skin Health Dis; 2024 Feb; 4(1):e297. PubMed ID: 38312258
[TBL] [Abstract][Full Text] [Related]
37. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation.
Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R
Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732
[TBL] [Abstract][Full Text] [Related]
38. The hyperimmunoglobulin E syndrome--clinical manifestation diversity in primary immune deficiency.
Szczawinska-Poplonyk A; Kycler Z; Pietrucha B; Heropolitanska-Pliszka E; Breborowicz A; Gerreth K
Orphanet J Rare Dis; 2011 Nov; 6():76. PubMed ID: 22085750
[TBL] [Abstract][Full Text] [Related]
39. Recurrent Skin and Lung Infections in Autosomal Dominant Hyper IgE Syndrome with Transactivation Domain STAT3 Mutation.
Cooper CJ; Said S; Hernandez GT
Case Reports Immunol; 2014; 2014():136752. PubMed ID: 25379309
[TBL] [Abstract][Full Text] [Related]
40. Hyper IgE (Job's) syndrome: a primary immune deficiency with oral manifestations.
Freeman AF; Domingo DL; Holland SM
Oral Dis; 2009 Jan; 15(1):2-7. PubMed ID: 19036057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
